α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's disease.
Cole TA, Zhao H, Collier TJ, Sandoval I, Sortwell CE, Steece-Collier K, Daley BF, Booms A, Lipton J, Welch M, Berman M, Jandreski L, Graham D, Weihofen A, Celano S, Schulz E, Cole-Strauss A, Luna E, Quach D, Mohan A, Bennett CF, Swayze EE, Kordasiewicz HB, Luk KC, Paumier KL.
Cole TA, et al. Among authors: jandreski l.
JCI Insight. 2021 Mar 8;6(5):e135633. doi: 10.1172/jci.insight.135633.
JCI Insight. 2021.
PMID: 33682798
Free PMC article.